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Abstract
Miles–Carpenter syndrome (MCS) was described in 1991 as an XLID syndrome with ﬁngertip arches and contractures and
mapped to proximal Xq. Patients had microcephaly, short stature, mild spasticity, thoracic scoliosis, hyperextendable MCP
joints, rocker-bottom feet, hyperextended elbows and knees. A mutation, p.L66H, in ZC4H2, was identiﬁed in a XLID re-
sequencing project. Additional screening of linked families and next generation sequencing of XLID families identiﬁed three
ZC4H2mutations: p.R18K, p.R213W and p.V75in15aa. The families shared some relevant clinical features. In silico modeling of
the mutant proteins indicated all alterations would destabilize the protein. Knockout mutations in zc4h2 were created in
zebraﬁsh and homozygous mutant larvae exhibited abnormal swimming, increased twitching, defective eye movement and
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pectoral ﬁn contractures. Because several of the behavioral defects were consistent with hyperactivity, we examined the
underlying neuronal defects and found that sensory neurons and motoneurons appeared normal. However, we observed a
striking reduction in GABAergic interneurons. Analysis of cell-type-speciﬁc markers showed a speciﬁc loss of V2 interneurons in
the brain and spinal cord, likely arising frommis-speciﬁcation of neural progenitors. Injected human wt ZC4H2 rescued the
mutant phenotype.Mutant zebraﬁsh injectedwith humanp.L66Hor p.R213WmRNA failed to be rescued,while the p.R18KmRNA
was able to rescue the interneuron defect. Our ﬁndings clearly support ZC4H2 as a novel XLID gene with a required function in
interneuron development. Loss of function of ZC4H2 thus likely results in altered connectivity of many brain and spinal circuits.
Introduction
Miles–Carpenter syndrome (MCS) is an X-linked intellectual dis-
ability (XLID) syndrome ﬁrst described in 1991 (1). The syndrome
was characterized by males having short stature, microcephaly,
exotropia, long hands, digit contractions, rocker-bottom feet
and spasticity along with severe intellectual disability. A distin-
guishing feature was the presence of an excess of arch ﬁnger-
prints or a low total ridge count. Additionally, it was one of the
few XLID syndromes in which the carrier females have some
somatic features, as well as mild cognitive impairment.
X-linked intellectual disability conditions account for about
two out of 1000 males with intellectual disability (ID) and are
quite heterogeneous. An estimated 150–200 genes are presumed
to be responsible for XLID of which only about 100 have been
identiﬁed. Indeed 30 XLID syndromes and 50 mapped families
with non-syndromal XLID are without a known causative gene
mutation (http://www.ggc.org/research/molecular-studies/xlid.
html). In order to address this gap, a large collaborative resequen-
cing project of 718 X genes in 208 XLID probands, (IGOLD, Inter-
national Genetics of Learning Disability), was undertaken using
Sanger sequencing to identify novel XLID genes (2). Besides iden-
tifying nine XLID genes, it generated over 500 non-recurrent
missense mutations. As a partial follow-up of this project, 15 pro-
bands were sequenced for the same 718 genes using next gener-
ation sequencing. Novel, non-recurrent missense mutations were
then pursued further. One such missense mutation, p.L66H, was
identiﬁed in ZC4H2, a zincﬁnger gene forwhich very little informa-
tion was available. Therefore, additional testing of families was
undertaken. Screening of families linked to Xq11 and next gener-
ation X-exome sequencing of small XLID families identiﬁed two
additional ZC4H2 mutations, a missense mutation, p.R213W, and
an in-frame insertion of 15 amino acids, p.V75in15aa. Independ-
ently, a third ZC4H2missense mutation, p.R18K, was identiﬁed in
a familywithXLIDusingwhole exomesequencing (WES). Biophys-
ical in silicomodeling indicated all three missense mutations were
destabilizing. Functional studies, using two KO zebraﬁsh mutants
created using the TALEN methodology, allowed us to determine
that ZC4H2 is important for the speciﬁcation and generation of a
subset of central nervous system (CNS) interneurons. In addition,
rescue experiments indicated that the L66H and R213Wmutations
result in loss of protein function. Further studies of ZC4H2will pro-
vide a better appreciation for the important role this gene plays in
brain development and function.
Results
Mutations in ZC4H2
Family K8070
Next generation resequencing of 718 genes located on the
X-chromosome identiﬁed a mutation, c.197T>A; p.L66H, in a male
from K8070 (Fig. 1). This family was previously published as having
MCS, an XLID condition with severe ID, macrocephaly, contractures
and exotropia (Table 1) (1). The syndrome was mapped to a broad
region of the X, spanning from Xp11.4 to Xq22.2. The location of
ZC4H2 in Xq11.2 was consistent with this localization and segrega-
tion of the c.197T > A mutation was found in K8070 (Fig. 1A). The
c.197T >A mutation was not listed in dbSNP nor in the 1000 Gen-
ome database. Additionally, a separate analysis of 1302 normal X
chromosomes failed to detect the change, further substantiating
c.197T >Awas not a rare polymorphism. Bioinformatic analysis re-
vealed themutationwas likelypathogenic (Table 2). TheL66 residue
was also observed to be highly conserved down to Candida tropicalis.
Family K8615
Once the L66Hmutation in ZC4H2was found inK8070, 30 families
within the Greenwood Genetic Center (GGC) cohort of XLID fam-
ilies with linkage to Xq11 were screened for additional ZC4H2
mutations. The proband in family K8615 was found to have a
p.R213W (c.637C > T) missense mutation. The mutation segre-
gated in the family (Fig. 1B). The family has three affected
males in three different sibships. The presentation was different
from that of K8070 (Table 1). Contractures were only present at
the knees and only one male had a club foot. Spasticity was
noted in one male, but both males had motor developmental
delay and ID. The carrier females did not exhibit any somatic fea-
tures, but one had mild ID. The R213 residue is highly conserved
down to Drosophila and bioinformatic analysis indicated it was
very likely to be pathogenic (Table 2).
Family K9333
As part of a focused, NINDS funded, next generation sequencing of
the X chromosome-exome of families with XLID, another ZC4H2
mutation, c.225 + 5G>A, was found in a family with three affected
males in three generations (Fig. 1C). No localization datawere avail-
able due to the structure of the family and the lack of a sample on
one affected male (II-5, Fig. 1C). The alteration segregated in the
family and was found to cause a splicing defect resulting in an
in-frame insertion of 15 novel amino acids, p.V75in15aa (Fig. 2).
Additionally, thewt transcript was not observed by RT–PCR. The af-
fected males presented with a phenotype different from MCS and
K8615 (Table 1). They had hypotonia, which progressed to spasti-
city, 3+ reﬂexes, microcephaly and severe developmental delay.
No contractures were noted. Nor did the affected males have sei-
zures. The carrier females were normal.
Family K9611
After whole-genome sequencing of the proband (II-4, Fig. 1D) and
his mother (I-2), X-linked variants were identiﬁed comparing the
genome sequences of patient II-4 and his mother I-2. Fifty-two
variants present in the heterozygous mother were transmitted
to II-4, 16 of which are not present in the dbSNP or in the 1000
genomes database. Eight of these 16 variants map to the linkage
region and cosegregation in the familywas determined by Sanger
resequencing of individual amplicons. Four of the eight variants
caused a missense mutation, but only one of these, R18K in
ZC4H2, had a high Polyphen-2 score (0.97) suggesting a deleteri-
ous effect on protein function (Table 2).
Human Molecular Genetics, 2015, Vol. 24, No. 17 | 4849
Tissue expression of ZC4H2
ZC4H2 expression analysis of human tissue was conducted
using RT–PCR and a multiple human fetal tissue cDNA panel
(Clontech). The expression of two different ZC4H2 transcripts,
ENST00000374839 (224 amino acids) and ENST00000337990 (201
amino acids), was examined because, although, the R18H muta-
tion does exist in the primary transcript of 224 amino acids, it was
not present in the shorter form of 201 amino acids (Supplemen-
taryMaterial, Fig. S1A). Thus, the expression level acrossmultiple
tissues was explored for both transcripts. As seen in Supplemen-
tary Material, Figure S1B, both transcripts are expressed in the
brain with the shorter one perhaps at a higher level. The long
form is apparently not present in the liver. Since both transcripts
were present in fetal brain, we examined the level of expression
in different regions of human brain using a Rapid Scan Human
Brain Panel (Origene). The ﬁndings were quite revealing (Supple-
mentary material, Fig. S1C). The short form, missing exon 1 and
the R18 residue, was highly expressed in all regions of the brain
and the spinal cord. The long form was weakly expressed in all
regions with perhaps higher expression in the hypothalamus,
pons andmedulla. It was not observed in the spinal cord sample.
These observationsmight explain themildness of the phenotype
observed in the family with the R18H mutation relative to the
other families, such as the lack of hypotonia, seizures and
hyperreﬂexia in the affected males (Table 1).
In silicomodeling of ZC4H2mutations
Although the bioinformatic analyses indicated all four ZC4H2
mutations were likely pathogenic (Table 2), we undertook in silico
analyses to predict the effect the three missense mutations had
on the stability of the ZC4H2 protein. The experimental 3D struc-
tures of wild-type and mutant ZC4H2 proteins are not available
and were modeled in silico as outlined in the Materials and
Methods section.
R18K mutation
In comparing the predicted structures for the WT and mutant
R18K, we were able to predict that the mutation will likely be de-
stabilizing. Using the criteria described in the Materials and
Methods section, we were able to reduce the ﬁve models in
three force ﬁelds for a total of 15 structure options down to
three viable options: model2 for Amber and Charmm and
model3 for Amber force ﬁelds. A visual inspection of these mod-
els revealed that R18 forms two hydrogen bondswith the glutam-
ic acid at position 106 (E106) in the model2 Amber WT structure
(Supplementary Material, Fig. S2A), and three hydrogen bonds
with E106 in model2 Charmm (Supplementary Material,
Fig. S2B). No hydrogen bonds were formed between these resi-
dues in model3 Amber (Supplementary Material, Fig. S2C).
Instead R18 is completely exposed to the water phase, which
would allow it to form favorable hydrogen bonds with water.
Figure 1. Pedigrees of the four familieswithmutations in ZC4H2. The genotype for each familymutation is given for individuals studied. X-inactivation data for thewomen
is given below each female. (▪) affected male; ( ) carrier female as determined either by pedigree structure or ZC4H2 analysis.
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The folding free energy (ΔΔG) of model2 Amber and Charmm
were both predicted to be destabilizing; however, the ΔΔG of
model3 Amber was predicted to be stabilizing. The overall aver-
aged ΔΔG is destabilizing but with a large deviation. The results
of the energy calculations and the potential loss of favorable
hydrogen bonds when R18 is mutated to K18 lead to our predic-
tion that this mutation will be destabilizing and therefore poten-
tially disease-causing. This prediction is consistent with third
party predictors and online webservers FoldX, Eris, PoPMuSiC,
I-Mutant 2.0 and PolyPhen-2, all of which predicted destabiliza-
tion of the gene due to the mutation (Supplementary Material,
Table S1).
L66H mutation
For the L66Hmutation, our criteria allowed for only onemodel to
be included in the analysis: model5 Charmmforce ﬁeld. The
model showed L66 being buried within the protein and protected
from the water with no charged residues surrounding it (Supple-
mentaryMaterial, Fig. S3). This is an ambiguous alteration to pre-
dict, since it involves a titratable residue, the His residue, whose
standard pKa is 6.5. No attempt was made to calculate the
apparent pKa of H66 in the models because none of the existing
predictors allows for protonation state adjustment. In our mod-
eling, the H66 was kept fully ionized. The prediction of the aver-
age ΔΔG is destabilizing but no deviation can be given since only
onemodel was used. All of the third-party servers agreed in their
prediction of the mutation to be destabilizing (Supplementary
Material, Table S1). This is what is expected since a replacement
of the hydrophobic Leu with a charged His at position 66 in the
hydrophobic core should be destabilizing.
R213W mutation
We were able to include three models for the R213W mutation
including: model2 Charmm, and model4 Amber and Charmm
(see Supplementary Material). Model4 Amber showed R213
forming two hydrogen bonds with the backbone oxygen at pos-
ition 221 (Supplementary Material, Fig. S4), while all other mod-
els had R213 exposed to the water. Our energy results showed
the R213W mutation would result in destabilization but the
standard deviation is signiﬁcant. All of the other servers also
predicted this mutation to be destabilizing (Supplementary ma-
terial, Table S1).
Table 1. Clinical ﬁndings in four families with ZC4H2 mutations
Kindred K8070a K8615a,b K9333 K9611a,b,c Totals
ZC4H2 mutation p.L66H p.R213W p.V75in15aa p.R18K
Affected individuals 4M 6F 3M 4F 3M 3F 4M 4F 14M 17F
Growth
Short stature (<3) 4/4 0/6 0/3 0/4 3/3 — 3/3 1/4 10/13 1/14
Microcephaly (<3) 3/4 1/6 0/3 0/4 3/3 — 3/3 0/4 9/13 1/14
Adaptation
Respiratory distress 0/4 0/6 0/3 0/4 0/2 — 0/3 — 0/12 0/10
Poor feeding 2/4 0/6 0/3 0/4 1/2 — 0/3 1/1 3/12 1/11
Motor developmental delay 4/4 2/6 3/3 0/2 3/3 — 3/3 1/1 13/13 3/9
Facies
Ptosis 2/4 2/6 0/3 0/4 0/2 — 3/3 0/1 5/12 3/11
Exotropia 4/4 5/6 1/2 0/2 — — 0/3 0/4 5/9 5/11
Long philtrum 2/4 4/6 0/3 — 0/1 — 3/3 0/1 5/11 4/7
High-arched palate 4/4 2/6 0/2 0/2 0/1 — 3/3 — 7/10 2/8
Broad alveolar ridges 3/4 2/6 0/2 — — — 0/3 0/1 3/9 2/7
Carp-shaped mouth 2/4 0/6 0/3 0/2 0/2 — 0/3 0/1 2/12 0/9
Skeletal
Narrow shoulders/thorax 4/4 2/6 0/3 0/4 1/2 — 3/3 — 8/10 2/10
Kyphosis, lordosis, scoliosis 4/4 2/5 0/3 0/4 3/3 — 3/3 — 10/13 2/9
Hip dislocation or contracture 0/4 1/6 0/3 0/4 0/1 — 0/3 0/1 0/11 1/11
Knee or elbow contractures 3/4 6/6 2/3 0/4 0/2 — 3/3 — 9/13 6/10
Camptodactyly 4/4 3/6 0/3 0/4 0/2 — 0/3 0/1 4/12 3/11
Ulnar deviation of ﬁngers 4/4 0/5 0/3 0/4 0/2 — 0/3 0/1 4/12 1/10
Club foot/rocker-bottom feet/ﬂat feet 4/4 0/6 1/3 0/4 0/2 — 3/3 0/1 8/12 0/11
Short neck 0/4 0/6 0/3 0/4 0/2 — 3/3 — 3/12 0/10
Neuromuscular
Distal muscle weakness 4/4 1/6 3/3 0/4 0/3 — 3/3 — 10/13 1/10
Spasticity/hyperreﬂexia 3/4 0/6 3/3 0/4 3/3 — 0/3 0/1 9/13 0/11
Seizures 1/4 0/6 0/3 1/4 2/3 1/1 0/3 0/1 3/13 2/12
Drooling 4/4 0/6 2/3 0/4 3/3 — 0/3 — 9/13 0/10
Hypotonia 4/4 0/6 0/3 0/4 2/2 — 0/3 — 6/12 0/10
Other
Intellectual disability 4/4 4/5 3/3 2/4 3/3 — 3/3 1/1 13/13 7/11
MRI abnormality 0/1 — 0/1 — 1/1 — 1/1 — 0/4 —
aK8070 showed an excess of ﬁngerprint arches in all males and females and cataracts in 1/4 males and 1/5 females.
bK8615 showed athetoid/dystonic movements of the hands in 2/2 males.
cK9611 showed palmar hyperkeratosis in 3/3 males, Sidney lines in 3/3 males and 1/1 female, and small testes and penis in 3/3 males.
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Immunoﬂuorescence studies of wild-type and R213W
in Cos-7 cells
As a preliminary analysis of the effect of themissensemutations
on the ZC4H2 protein, immunoﬂuorescence studies were con-
ducted in Cos-7 cells using GFP-tagged wt-type and mutant con-
structs.We noticed that in Cos-7 cells transfectedwith ZC4H2-wt,
most of the protein resided in the nucleus (Supplementary Ma-
terial, Fig. S5A). For two of the missense mutations, ZC4H2-
R18K and ZC4H2-L66H, their location pattern was not much dif-
ferent from wild-type. However, for Cos-7 cells transfected with
ZC4H2-R13W, the majority of the protein still resided outside of
the nucleus (Supplementary Material, Fig. S5A). Because of this
observation, the ZC4H2 protein was analyzed to see if it con-
tained a nuclear localization signal (NLS). Using an NLS predictor
(http://www.moseslab.csb.utoronto.ca/NLStradamus), a NLS
domain was predicted to be contained within amino acids
207–224 (KAKSRSRNPKKPKRKQDE). Residue R213 (underlined) is
located in this stretch of amino acids. Thus, the immunoﬂuores-
cence data indicate the R213W mutation perturbs the NLS
domain which might inﬂuence whatever function the ZC4H2
protein has within the nucleus, thereby contributing to the
phenotype of males in family K8615 relative to males with
other ZC4H2 mutations.
Table 2. Bioinformatic analysis of missense mutations in ZC4H2
R18K L66H R213W
Consurf results Exposed residue /Highly conserved Buried residue /Highly conserved Exposed residue /Highly conserved
ipTree Destabilizing Destabilizing Destabilizing
MuStab Decreased stability Decreased stability Increased stability
Mutation tasting Disease causing Disease causing Disease causing
pMut Neutral Pathological Pathological
Polyphen Damaging Damaging Damaging
SIFT Tolerated Not tolerated Not tolerated
Conserved Conserved down to gallus Conserved down to tropicalis Conserved down to Fugu
Domain zf-C4H2 coiled-coil domain zf-C4H2 coiled-coil domain No
Figure 2. Partial analysis of ZC4H2 cDNA in family K9333. (A) RT–PCR of ZC4H2 mRNA prepared from individuals III-2 and III-3 in family K9333 using 4% agarose.
(B) Sequence of ZC4H2 from individuals III-2 and III-3 ﬂanking the exon 2/exon 3 boundary. The schematic shows how the insertion of 45 bp in III-2 results from the
c.225 + 5G >A mutation. Bases in the transcripts are in capital letters. Red letters indicate intron 2 sequence. The mutation site is indicated with an asterisk.
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Spatiotemporal expression pattern of zebraﬁsh zc4h2
To determine the potential function of ZC4H2 and the pathogen-
icity of the missense mutations in human patients, we chose to
use a zebraﬁsh model, which allows rapid genetic, behavioral
and embryological experimental analysis of a vertebrate nervous
system. Using whole-mount in situ hybridization, the spatio-
temporal expressionof the zc4h2 ortholog during zebraﬁsh embry-
onic development was explored. zc4h2 transcripts were mainly
detected throughout the developing CNS, but were excluded
from the most medial ventricular zone suggesting expression
in differentiating progenitors and mature neurons and/or glia
(Fig. 3). Based on our observation of human ZC4H2 nuclear local-
ization of in Cos-7 cells, the cellular localization of the zebraﬁsh
zc4h2 gene product was examined. As shown in Supplementary
Material, Figure S5B, ecotopically expressed Zc4h2 was located
mainly in the nucleus of zebraﬁsh cells.
Generation of zebraﬁsh zc4h2mutants
Two independent zebraﬁsh zc4h2 null mutant alleles were cre-
ated using TALEN methodology (Supplementary Material,
Fig. S6). Homozygous mutant ﬁsh were viable beyond embryo-
genesis, and all mutant larvae exhibited abnormal ﬂexion of
the pectoral ﬁns and abnormally positioned eyes when com-
pared with wild-type siblings (Fig. 4A–D). These ﬁndings are con-
sistent with the contractures and exotropia observed in the
human patients with ZC4H2 mutations. Additionally, at 5 days
post-fertilization (dpf), all mutant larvae exhibited active move-
ments of the pectoral ﬁns, continuous swimming movements
and balance problems (Supplementary material, Videos S1 and
S2), compared with wild-type siblings that had saccadic eye
movements and were mostly stationary (Supplementary mater-
ial, Videos S3 and S4). The mutants also exhibited an open
mouth as well as continuous jaw movements (Supplementary
material, Video S5).
Based on the expression of zc4h2 in the CNS during early devel-
opment and the apparent hyperactivity exhibited by the ﬁsh, an
anatomical analysis was undertaken using markers for speciﬁc
classes of neurons. To address a potential motoneuron defect re-
ported after morpholino knockdown of the gene (3), we stained
wild-type and mutant ﬁsh at 24 h with an antisense probe for
isl1 mRNA and a znp-1 (anti-synaptotagmin 2) antibody, both
known markers for zebraﬁsh motoneurons (4,5). Surprisingly, we
observed no differences betweenwild-type and zc4h2mutant em-
bryos foreitherof thesemarkers (Supplementarymaterial, Fig. S7).
However, in mutant embryos, expression of both vsx2, which la-
bels V2a interneurons (6), and vsx1, which labels V2a/b inter-
neuron precursors (7), was signiﬁcantly decreased throughout
the CNS (Figs 4E,F and 5A–D). To assess whether loss of V2 neuron
markers was correlated with altered neural progenitor speciﬁca-
tion, we examined the expression of dbx2 and nkx6.1, markers
for adjacent p1 andp2 progenitor domains, respectively (8). Inmu-
tant embryos, dbx2 expressionwas clearly expanded, with a corre-
sponding loss of nkx6.1 expression in the midbrain tegmentum,
hindbrain and spinal cord (Fig. 5E,F and I–L). Interneuron defects
Figure 3.Whole-mount in situhybridization of the zebraﬁsh ZC4H2 ortholog, zc4h2. (A and B)Wholemount in situhybridization at 48 hpf. (C–E) Sections cut at the positions
indicated in (B). zc4h2 shows CNS-speciﬁc expression outside the ventricular zone where stem cells are found.
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appeared to be restricted to populations arising from these pro-
genitor domains, as expression of dlx2a,whichmarks interneuron
precursors in the forebrain, was unaffected (Fig. 5G–H).
Consistent with the defects observed in V2markers, we found
a signiﬁcant reduction in the number of GABAergic neurons in
the intermediate spinal cord of mutant embryos as evidenced
by decreased staining for gad1 (Fig. 5M and N). Decreased expres-
sion of gata3, which encodes a transcription factor important for
the generation of V2b inhibitory neurons (9), was also observed in
mutant embryos (Fig. 5O and P). In addition, ectopic expression of
glyt2a, a marker for glycinergic neurons, was observed in this
same region inmutants (Fig. 5Q and R). In contrast, no difference
between mutants and wild-type siblings was observed when
vglut2.1, a marker for glutamatergic excitatory neurons, was ex-
amined (Fig. 5S and T). By 33 hpf, a reduction in GABAergic inter-
neurons was observed in the midbrain tegmentum region of
zc4h2 mutants, which is thought to control pectoral ﬁn and jaw
movements (Supplementary Material, Fig. S8A and B) (10). Fur-
ther analysis showed similar reductions in the expression of
both gata2 and gata3 in the spinal cord, hindbrain neurons and
the midbrain tegmentum at 24 hpf (Supplementary Material,
Fig. S8C–F). Additionally, the expression of scn1Lab, a voltage-
gated sodium channel expressed in inhibitory interneurons
(11), was slightly decreased (Supplementary material, Fig S8G
andH). Together, these data suggest that zc4h2 functions to regu-
late the speciﬁcation of p2 CNS progenitors, which normally gen-
erate a population of primarily GABAergic interneurons (Fig. 5U).
Human ZC4H2mutations affect the ability to rescue
zebraﬁsh mutants
To explore the pathogenic nature of the three missense muta-
tions in ZC4H2, wild-type and mutant human ZC4H2mRNA con-
structs were injected into zc4h2mutant zebraﬁsh 1-cell embryos
and expression of gad1 was examined at 24 h. Wild-type human
ZC4H2mRNAwas able to restore gad1 expression (Fig. 6A and C, G
and I), as well as the behavioral phenotype (Supplementary
material, Video S6). However, both L66H and R213W mRNAs
were only able to partially rescue gad1 expression (Fig. 6D and
E, J and K), consistent with both mutations being pathogenic as
predicted both bioinformatically and by in silico structural model-
ing. Interestingly, the R18K mRNA was able to restore gad1
expression (Fig. 6F and L), consistent with family K9611 having
a somewhat milder phenotype (Table 1).
Discussion
XLIDs comprise many entities, some syndromic and many non-
syndromic without any distinguishing clinical ﬁnding other than
ID.With respect to themore than 110 syndromal XLID conditions,
many present withmicrocephaly or spastic paraplegia. However,
few present with scoliosis or congenital contractures. Therefore,
identiﬁcation of the genetic cause for a syndromewith all four of
these clinical ﬁndings would likely prove to be quite informative
as to their interconnection.
We have identiﬁed four mutations in ZC4H2, three missense
and one in-frame insertion, in the original family with MCS and
three other families with a constellation of microcephaly, short
stature, contractures, spasticity and ID.
ZC4H2 is located in Xq11.2 and ﬁndingmutations in four fam-
ilies in our study alongwithmutations in another ﬁve families (3)
is consistent with the clustering of both XLID genes and families
in the pericentric region of the X chromosome. Of the 170 XLID
entities (syndromic and non-syndromic) with a gene ﬁnding, 70
(41%) of them are localized to the pericentric region and of the
known 114 XLID genes, 50 (44%) are located in this same region
(http://www.ggc.org/research/molecular-studies/xlid.html). The
reason for this clustering is not evident at this time.
ZC4H2 is a zinc-ﬁnger protein belonging to the family of pro-
teins with a C-terminal zinc-ﬁnger domain characterized by four
cysteine residues and two histidine residues. Additionally, ZC4H2
has a coiled-coil domain. However, little was known about the
Figure 4. Frames frommovies of wild-type sibling (wt) and zc4h2 KOmutant (mut) embryos. (A–D) At, 5 dpf, dorsal views showing normal positioning of ﬁns and eyes in a
wt larva (A and C) and abnormally ﬂexed ﬁns and outward positioning of eyes in a zc4h2 homozygous mutant larva (B and D). Larvae were positioned in 3%
methylcellulose. (E and F) Dorsal views showing absence of vsx2 expression, which labels hindbrain interneurons, in 3 dpf mutant larvae.
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Figure 5.Whole-mount in situ hybridization for neural markers in wild-type sibling (wt) and zc4h2 KOmutant (mut) zebraﬁsh. (A–D) At 24 h, expression of vsx2 and vsx1,
markers for V2a interneurons and V2a/b precursors, respectively, was signiﬁcantly reduced in the brain and spinal cord ofmutants. (E and F) At 33 hpf, expression of dbx2
(blue) was increased and expression of nkx6.1 (red) was decreased in the midbrain tegmentum (*). and hindbrain of mutants. (G and H) At 35 hpf, expression of dlx2a, a
marker of forebrain GABAergic precursors, was unaffected inmutants. (I–L) At 24 hpf, expression of dbx2was increased and expression of nkx6.1was decreased (brackets)
in the spinal cord ofmutants. (M andN) Expression of gad1, amarker for GABAergic neurons, was decreased in V2 interneuron territories of themutant spinal cord (White
rectangles). (O and P) gata3 expression, a marker for V2b inhibitory interneurons, was dramatically reduced in the mutant spinal cord. (Q and R) glyt2a, a marker for
glycinergic neurons, was ectopically expressed in the mutant spinal cord. (S and T) vglut2.1 expression, a marker for glutamatergic excitatory neurons, was unaffected
in zc4h2 homozygous mutant zebraﬁsh. (U) Model for Zc4h2 function in zebraﬁsh interneuron speciﬁcation.
Figure 6. Rescue of gad1 expressing interneurons in zebraﬁsh zc4h2 KOmutant by injection of human ZC4H2mRNAs. (A and B) gad1 transcripts in uninjected control wild-
type sibling (wt) and zc4h2 homozygous mutant (mut) embryos at 24 hpf. (C–F). Rescue experiments with mRNA containing the indicated human ZC4H2 WT and
mutations. White rectangles indicate V2 interneuron territories. (G–L) Quantitative analysis of gad1 transcripts in zc4h2 mutant (mut) embryos with and without
injected mRNA. **P < 0.001, *P < 0.05.
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function of the ZC4H2 protein other than it was proposed as a can-
didate gene for XLID based on a computational approach (12). Our
in silicomodeling of the effects of these three missense mutations
of thewt properties of ZC4H2 protein predicted that themutations
woulddestabilize the structure of ZC4H2 and thuswould indirectly
affect its function.
The phenotypes of the families reported by Hirata et al. (3) and
here (Table 1) have quite similar clinical ﬁndings. Family 1 in
Hirata et al. (3), reported as Wieacker–Wolff syndrome (13), was
not originally considered as having arthrogryposis multiplex
congenita. Rather, both Wieacker–Wolff syndrome and MCS ap-
pear to have had some lower limb musculoskeletal ﬁndings at
birth, but clearly not something suggestive of early onset arthro-
gryposis. It is possible that both syndromes, as well as our three
other families represent a condition that is progressive in nature.
In order to unravel the function(s) of the ZC4H2 protein, two
zebraﬁsh mutant alleles were generated using TALEN method-
ology. Homozygous mutant larvae for both alleles showed
motor hyperactivity, abnormal swimming and continuousmove-
ment of their jaws. The ﬁsh also exhibited contractures of the
pectoral ﬁns and abnormal eye positioning suggestive of extro-
pia. Together, these phenotypes are highly reminiscent of the
human patients carrying ZC4H2 mutations, indicating that our
zebraﬁshmodel can be used to determine the underlying cellular
and molecular mechanisms of motor dysfunction.
Contrary to a previous study carried out using morpholino
knockdown of zc4h2 (3), we observed no defects in motoneurons
or tail coiling of mutant larvae (Supplementary Material, Video
S7 and Figs S7 andS9). It is therefore possible that someof the zeb-
raﬁsh phenotypes observed in this earlier work may have been
due to off-target effects of morpholinos (14). Instead, we observed
a clear loss of multiple markers of the V2a and V2b interneuron
lineages in the hindbrain and spinal cord, as well as loss of
GABAergic neurons in the midbrain tegmentum. In addition, we
observed accompanying ectopic glycinergic neurons in the ventral
spinal cord, consistentwith a defect in neuronal fate speciﬁcation.
Analysis of neural progenitor markers strongly suggested that the
loss of V2 interneurons results frommis-speciﬁcation of adjacent
spinal cord progenitor domains. Intriguingly, the neuronal sub-
types that are speciﬁcally affected in mutant larvae provide a po-
tential physiological basis for the behavioral phenotypes observed
in both zebraﬁsh and humans. While we cannot rule out an add-
itional role for ZC4H2 in excitatory synaptic function as previously
reported (3), these ﬁndings were based on overexpression studies
of GFP-tagged protein and may not reﬂect an endogenous role.
Furthermore our data indicate that wild-type protein tagged
with small epitopes is primarily localized to the nucleus when ex-
pressed in both Cos-7 cells and zebraﬁsh embryos.
The presence of two isoforms for ZC4H2 with different levels
of expression in tissues and sections of the brain likely contri-
butes to the broad clinical spectrum of involvement of the central
and peripheral nervous systems observed in our four families
and those reported by Hirata et al. (3). Additionally, it is quite pos-
sible ZC4H2 has more than one function as it contains both a
zinc-ﬁnger domain and a coiled-coil domain. These possible ex-
planations for the clinical variability are evident in that males in
family K8615 whose mutation, R213W, affects nuclear localiza-
tion of the proteins, do not exhibit the narrow shoulders, kypho-
sis nor degree of distal contractures observed in the other families
and males in family K9333 whose mutation, R18K, would not be
present in the short form of ZC4H2 do not present with spasticity,
drooling and hypotonia.
In summary, ourwork provides a novelmechanisticmodel for
the etiology of MCS and other XLID entities with mutations in
ZC4H2. The expression of ZC4H2 in the developing CNS, as well
as the neuroanatomical defects in zebraﬁsh mutants, suggest a
required function in neural tube progenitor speciﬁcation that
ultimately affects interneuron fate and connectivity throughout
the brain and spinal cord. Because loss of GABAergic neurons is
the most prominent phenotype arising from this mis-speciﬁca-
tion, ZC4H2 loss of function may therefore result in hyperexcit-
ability of multiple brain and spinal circuits.
Materials and Methods
Clinical reports
Fourteen males were affected in the four kindreds (Table 1). The
14 prominent ﬁndings, i.e. those occurring in over 50% of males,
included intellectual disability, motor and speech delay, short
stature, microcephaly, distal muscle weakness, foot abnormal-
ities (rocker-bottom, pes planus, club foot), knee and/or elbow
contractures, narrow shoulders and upper torso, ptosis and/or
exotropia, long philtrum, highly arched palate, spinal curvature
(kyphosis, scoliosis, lordosis), hypotonia and/or drooling and
spasticity.An excessive number ofﬁngerprint archeswas present
in all affected males and females in K8070 but was not noted in
the other kindreds.
Seventeen carrier females were identiﬁed in the four kindreds.
Clinical informationon the females ismost complete inK8070 and
K8615, somewhat complete in K9611 and not available in K9333
(Table 1). Growth was typically normal but with head circumfer-
ence and stature in the lower centiles: only one carrier female
had short stature (<3rd centile) and only one had microcephaly
(<3rd centile). Although IQ measurements were not available,
most carrier females (seven out of 11) were considered to have
low or borderline cognitive function. None had hypotonia, drool-
ing or spasticity. Six females had elbow or knee contractures,
two had seizures, three had camptodactyly and two had narrow
shoulders/thorax. Craniofacial features were not distinctive al-
though several carrier females in K8070 had ptosis, long philtrum,
high-arched palate and broad alveolar ridges and all except 1 (ﬁve
out of six) had exotropia. Regarding X-inactivation (XI), it varied
within families (Fig. 1). Thus, it was difﬁcult to observe a correl-
ation between skewing of XI and the lack of phenotype in the
carrier females or the severity of the phenotype in males in
the family.
K8070
Clinical details of the four affectedmales and six affected females
were reported in 1991 (1). The prominent ﬁndings are given in
Table 1 and the pedigree shown in Figure 1A. The genewas linked
to DXYS1 at Xq 21.31 (lod score 2.788).
K8615
Three males in three generations are affected in this kindred
(Fig. 1B and Table 1). The carrier II-4 has intelligence in themildly
disabled range and has seizures. II-2 is said to function in the low
normal range. Neither have spasticity. III-3 is considered to be
normal.
II-1 had a birth weight of 4 kg. Club feet were present. Develop-
ment was globally delayed with sitting at 2 years, crawling at 2
years and only two indistinct words by 2 years. At 2 4/12 years,
his height was 85 cm (10th centile), weight 12.6 kg (20th centile)
and OFC 50.5 cm (75th–90th centile). The face appeared normal.
There was no nystagmus but some tongue protrusion, drooling
and dystonic movements of the oropharynx. Fifth ﬁnger clinodac-
tyly and horizontal palmer creases were present. The lower
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limbs showedweakmuscles, hypertonia, hyperreﬂexia, knee con-
tractures and several scars fromclub foot surgery.MRI at age 1 year
was normal. He now lives in a community living facility and has a
reported IQ of 60.
Few details are available on III-4 and III-5 except they are
intellectually disabled and have no speech, use wheelchairs for
ambulation and have lower limb weakness and spasticity.
K9333
Three males in two generations are affected in this kindred
(Fig. 1C and Table 1). Ptosis and a long philtrum have not been re-
cognized. Nor have narrow shoulders, contractures, camptodac-
tyly or ulnar deviation of the ﬁngers. All have had scoliosis.
II-4 (female) is reported to have a speech impediment,
seizures and abnormal gait. The father of III-4 had congenital
cataracts.
II-5 was globally delayed from birth. He fed poorly. He never
spoke, nor walked. He kept his arms and knees bent, but he did
not have contractures. He was considered to have cerebral
palsy. His maximum weight was 40 lbs. He had signiﬁcant scoli-
osis by the age of 10, but was not regarded as suitably robust for
any surgery. A prolonged seizure occurred on at least one occa-
sion. He died suddenly at age 22 years.
III-2, the nephew of II-5, had poor feeding in infancy and de-
layed development. It was suspected early that he had the same
condition as his uncle. He has had seizures, stenosis of the for-
amen magnum and upper cervical spine (not requiring surgery)
and scoliosis.
III-4, born 17 months after III-2, had a birth length of 48 cm
andweight of 3.2 kg. Bilateral cataracts, like his father’s, were pre-
sent. Development was globally delayed, and hewas soon recog-
nized as having the familial condition. Motor delay was apparent
by 6months. At 23months, hewas not sitting alone andhad poor
muscle tone and head control. Examination then showed length
79.5 cm (<3rd centile), weight 11 kg (20th centile) andOFC 44.5 cm
(<3rd centile), roving eye movements, increased startle reﬂex,
hypotonia, everted lower lip, hyperreﬂexia and Babinski reﬂexes.
MRI was unremarkable. He has continued to have profound de-
lays, but is aware of his surroundings. He does not have seizures.
K9611
The Italian family was ascertained through individual III-3
(Fig. 1D) who sought advice for her reproductive options, consid-
ering the presence of psychomotor delay and intellectual disabil-
ity in her two stepbrothers (III-4 and III-5) and hermaternal uncle
II-4. Individual IV-4 also reportedly had poor growth and psycho-
motor delay, still did not speak, and had not started primary
school at age of 7 years because of complicated pneumonia. Clin-
ical ﬁndings are reported in Table 1 and are brieﬂy summarized
here.
Patient II-4 is 59 years old. He is a gentle person living in a
sheltered residence. He speaks a few words and walks with
great difﬁculty. He has short stature (159 cm) and small head cir-
cumference (52.5 cm), small hands with short ﬁngers and no ﬁn-
gerprint arches. Patient III-4 is 36 years old. He has short stature
(157 cm) and small head circumference (52 cm), small handswith
short ﬁngers and one arch on the right index ﬁnger. Patient III-5 is
33 years old. He also has short stature (159 cm) and small head
circumference (52 cm), short palm with normal middle ﬁnger
and three ﬁngerprint arches. All patients have palmar hyperkera-
tosis and complete or partial Sidney line that is also observed in
examined female carriers. Also patients III-4 and III-5 had per-
sistence of deciduous teeth (premolars), while III-4 had two
connatal teeth in the lower jaw. All affected males (II-4, III-4
and III-5) had small testes and short penis.
While non-carrier females, like proband III-3 andher sister III-
1, have normal intelligence, heterozygous females have variable
degree of intellectual disability and have never excelled at school.
IV-3 is the only onewho completed high school but with individ-
ual support and personalized programs and, according to her
own mother, is the most intellectually impaired of the carriers.
The X-inactivation ratio using the androgen receptor CAG repeat
showed that IV-3 hadmarkedly skewedX-inactivationwith a 91:9
ratio. Given the close proximity of the ZC4H2 and AR genes in
Xq11.2-q12 (2.6 Mb apart), we deduce from haplotype analysis
that the ZC4H2 mutation is on the active X chromosome in in-
formative carrier females and is expressed in 91% of blood cells
of IV-3, compared to 72 and 71% in I-2 and II-2, respectively.
ZC4H2mutation detection
K8070
Exon capture and deep sequencing of 718 genes on the X-
chromosome was done as detailed in (15).
K8615
Screening of XLID families linked to the Xq12 region of the X
chromosome was conducted using M13 tagged primers for the
exons of ZC4H2. The PCR products were ampliﬁed and then puri-
ﬁed with ExoSap from USB. Using M13 primers and the ABI 3730
sequencer the PCR products were sequenced with BIGDye Ter-
minator v3.1 Cycle sequencing Kit from Life Technologies. The
sequence data were analyzed using SEQMAN from DNASTAR.
The R213W alteration was found in an affected male and then
tested and conﬁrmed in the entire family.
K9333
Genomic DNA samples from 82 XLIDmale samples [30 unrelated
and 52 related (26 sib-pairs)] were used to generate Illumina se-
quencing library using TruSeq DNA sample Preparation kits.
The X chromosome exome was enriched using an Agilent Sure-
Select X chromosome exome kit. Individual libraries were
uniquely barcoded and sequenced on the Illumina HiSeq2000
platform using either 75 bp or 100 bp pair-end read modules.
INDEL realignment and base recalibration were conducted
using GATK. Uniﬁed Genotyper (GATK) was used for variant call-
ing [parameters: –ploidy 1, all else at default]. The ﬁnal variant
output was pre-processed by removing variants with zero cover-
age from one strand and by removing variants in close proximity
(<10 bp) to another variant in the same sample. Such variants are
most likely to be erroneous.
Potential XLID variants were identiﬁed using a sib-pair com-
parison ﬁlter. Given the rarity of XLID, this ﬁlter assumes that un-
ique XLID mutations are rare and shared only between affected
family members. Variant output from sequencing was ﬁltered
by retaining only those variants shared between related samples
and by removing variants shared between unrelated samples in
our cohort. Additionally, variants shared with 162 male samples
(unaffected controls) from the 1000 Genomes project were
removed. This ﬁlter effectively reduced the total number of
variants from 1774 ± 240 variants per samples to 31 ± 5 variants
per sample, easing identiﬁcation of potential disease-causing
mutations.
K9611
DNAwas extracted from all individuals of generation II and III as
well as from I:2, IV:1 and IV:3 (Fig. 1D). Linkage was established
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betweenmarkers DXS993 (Xp11.4) and DXS8055 (Xq23) identifying
a minimal interval of 70 Mb. Considering the large interval and
the corresponding elevated number of candidate genes, whole-
genome diploid sequencing was performed on individuals I:2
and II:4 by Complete Genomics Inc. (Mountain View, CA, USA)
using a sequencing-by-ligation method as described by Drmanac
et al. (16). Brieﬂy, the human genome sequencing procedures
include DNA library construction, DNA Nano-Balls (DNBs) gener-
ation, DNB array self-assembling, cPAL-based sequencing,
imaging, imagedataanalyses including basecalling,DNBmapping
and sequence assembly. Data were provided as lists of sequence
variants (SNPs and short indels) relative to the reference genome.
Human Genome Build 36 was used as a reference to identify
sequence variations in each sample. Analysis was done using
Complete Genomics analysis tools (cga tools) and TIBCO Spotﬁre.
Conﬁrmation of ZC4H2 variants
The variants in ZC4H2 were conﬁrmed using Sanger Sequencing
in a second sample of genomic DNA. Once conﬁrmed, other
members of the four families were also sequenced.
Polymorphism analysis
Screening of normal control individuals (male and female) for the
ZC4H2 c.197T > A variant consisted of utilizing allele speciﬁc
ampliﬁcation (ASO) using primers:
ZC4H2 ASO K8070F 5′ATGGCCCATGTGGAGGAtCa 3′; ZC4H2
ASO K8070R 5′CACTACCACAGCCTGCACTGA 3′. A control ampli-
con was ampliﬁed using primers for ZNF711: ZNF711 ex 4AF
TTCCTGGTTGTTTGATTTT; ZNF711 ex 4AR ACAAGGTCAGCCACG
AAAAC. The ZC4H2 product was 177 bp and the ZNF711 product
was 498 bp. PCR products were used.
ZC4H2 tissue expression analysis
Human Fetal MTC panel (Clontech) was utilized for analysis of
ZC4H2 expression in fetal tissues. The MTC cDNA preparations
utilized for RT–PCR analysis were conducted as outlined by the
manufacture in a ﬁnal reaction volume of 20 µl. Primers for
ZC4H2 long were: ZC4H2 long cDNA F CCCTTGGCTGGTGTA
TTTGT; ZC4H2 long cDNARTAGGAGACTTCGTGGGGTTGand pri-
mers for ZC4H2 short were: ZC4H2 short cDNAF ATGGAAGAT
CAAGGCTCGTT; ZC4H2 short cDNAR TTATTCATCCTGCTTCC
GTTTC. Primers for the control gene, GAPDH were RT-F 5′-ATG
GGTCAGAAGGATTCCTATGTG-3′ and RT-R 5′-TGTTGAAGGTCTC
AAACATGATCTGG-3′. PCR conditions for ZC4H2 were: initial de-
nature 95°C at 5 min, followed by 30 cycles of denature at 95°C,
30 s, annealing at 57°C, 30 s and extension at 72°C, 40 s. Final ex-
tension was at 72° for 5 min. For GAPDH, the PCR conditions were
the same except the annealing was done at 55°C, the extension
was for 30 s and only 25 cycles were used. Ten microliters of
the PCR reaction were run on a 3% agarose gel in 1XTBE.
Cos7 transfection
RNA
RNA was prepared from a control cell line and from patient
lymphoblast cell lines using GenElute Mammalian Total RNA
Miniprep (Sigma catalogue number RTN-70).
Plasmid construction
cDNA was prepared with Superscript First Strand Synthesis Kit
for RT–PCR (Invitrogen catalogue number 11904-018) from 2 µg
of RNA prepared from lymphoblast cell lines. A PCR reaction
with the oligos 5′GGAGAGGGGGAAGCTTGTAA3′and 5′TAGGAG
ACTTCGTGGGGTTG3′ and PFUTurbo (Stratagene catalogue num-
ber 600250) was employed to generate the insert. The fragment
was run on a 1% TAE agarose gel and puriﬁed with a Gel Extrac-
tion Kit (Qiagen catalogue number 287040.) The puriﬁed product
was cloned into pcDNA3.1D/V5-His-Topo vector using the
pcDNA3.1 Directional Topo Expression Kit (Invitrogen catalogue
number K4900-01). All plasmids generated have a V5 tag on the
c-terminus. The LacZ V5 plasmid was included as a positive con-
trol with the kit. Plasmids were sequenced to conﬁrm the insert
with the vector speciﬁc primers PC (5′ GGG AGA CCC AAG CTG
GCT AGT 3′) and BGH (5′ TAG AAG GCA CAG TCG AGG 3′) and in-
sert speciﬁc primers 5′CACCATGGCAGATGAGCAAGAAATC3′ and
5′TTCATCCTGCTTCCGTTTCGGCTT3′. Site-directed mutagenesis
was done to create the following alterations: L66H and R213W
using the QuikChange II Site-Directed mutagenesis kit (Strata-
gene catalogue number 200524). All constructs were sequenced
to verify the alteration.
Cell culture
Cos-7 cells were obtained from American Tissue Culture Collec-
tion. The cells were cultured in DMEM (Sigma catalogue number
D5796) supplemented with 10% FBS (Atlanta Biologicals cata-
logue number S12450H), 1 × Penicillin/Streptomycin (Sigma cata-
logue number P0781), 2 m glutamine (Sigma catalogue number
G7513) in a 5% CO2 humidiﬁed 37C incubator.
Transfection
Cos-7 cells were cultured on poly--lysine (Sigmacatalogue num-
ber P4707) coated 24-well tissue culture dishes in growth media
18–24 h priors to transfection. A transfection complex containing
DMEM (Sigma catalogue number D5796), 1 µg of plasmid and 2 µl
of Lipofectamine 2000 (Invitrogen catalogue number 11668-027)
was prepared and added to each well. After 24 h, the transfection
complexes were removed, the cells washed one time with PBS
and growth media was added back to the cells. Twenty-four
hours post-transfection, the cells were moved to a poly--lysine
coated glass slip and cultured in growth media for 24 h.
Immunoﬂuorescence
The cells were washed twice with PBS, ﬁxed with 4% paraformal-
dehyde/PBS, permeabilized with 0.1% Trtiton X-100/PBS and
blocked with block (2% horse sera, 0.4% BSA in PBS). The cells
were incubatedwith anti-V5mousemonoclonal antibody (Invitro-
gen catalogue number R960.25), washed with block and incubated
withAlexaFluor 594anti-Mouse IgGandAlexa Fluor 488Phalloidin
(Invitrogen catalogue numbers A21200 and A12379), washed with
block, incubated with DAPI and mounted with Gold Prolong anti-
fade medium (Invitrogen catalogue number P36930).
ZC4H2modeling
Structures
X-ray structures are unavailable for Zinc Finger ZC4H2; therefore,
it was necessary to utilize the online webserver I-TASSER (http://
zhanglab.ccmb.med.umich.edu/I-TASSER/) (17) to create models
for the wild-type structure of ZC4H2. Using the ﬁve WT models
and the SCAP program, which is part of Jackal package (http://
wiki.c2b2.columbia.edu/honiglab_public/index.php/Software:
Jackal), we created separate structures for the three independent
point mutations investigated in this work (R18K, L66H and
R213W). Then theWT and themutant structures were energetic-
ally minimized with two force ﬁelds: Amber (18) and Charmm
(19). This resulted in total of 40 structures (ﬁve general models,
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each model including a WT, R18K, L66H and R213W version, and
each WT or mutated structure being minimized using the two
aforementioned ﬁelds).
The sequence similarity between the ZC4H2 sequence and
any available ﬁle in the Protein Data bank (PDB) (20) is very low
and it is anticipated that in silico generated models will be of
low quality. Since the goal is to assess the effect of single point
mutations on ZC4H2 protein stability, one can argue that global
structural feature will be less important than the local structural
arrangement. Because of that, we applied local structural consid-
erations to eliminate insufﬁcient models. The considerations are
as follows: (i) all of themodelswere submitted to a third party ser-
ver, Verify3D (http://nihserver.mbi.ucla.edu/Verify_3D/), which
provides an analysis of the quality of a model. Scores aremarked
on a scale of −0.5 to 1.0. Models below a particular manually se-
lected threshold value of 0.20 were eliminated; all models were
then visually inspected to verify acceptable structural features
including; (ii) the formation of favorable hydrogen bonds be-
tween the target and near-by residues; (iii) the hydrophilic R18
and R213 being exposed to the water phase and hydrophobic
L66 being at least partially buried or protected from the water
phase; (iv) to assure that like charges are either at distances great-
er that 6Å or are involved in hydrogen bonding; and ﬁnally (v) to
verify that the surrounding residue environment close to the tar-
get sites does not include unacceptable features such as buried
charged residues that are not involved in hydrogen bonds and
over packing. Only structural models satisfying these conditions
were used for the energy analysis (all models can be downloaded
from http://compbio.clemson.edu/ZC4H2).
Modeling the effect of mutations on ZC4H2
protein stability
The folding free-energy changes were calculated with the
Molecular Mechanics Generalized Born (MMGB) (21):
ΔGðfoldingÞ ¼ GðfoldedÞ  GðunfoldedÞ
¼ GðfoldedÞ  G0ðunfoldedÞ  GxðunfoldedÞ: ð1Þ
Where G(folded) is the total potential energy of the folded
state and the G(unfolded) is the total potential energy of the un-
folded state. The energy, G(unfolded), of unfolded state, is split
into two terms, G0(unfolded) and Gx(unfolded), as discussed in
our previous works (22,23).Gx(unfolded) is the energy of unfolded
state of ‘x’ residue segments at the center of mutation site, while
G0(unfolded) is the energy of unfolded state of the rest of protein.
Under such an assumption, the G0(unfolded) is identical for WT
and mutants and cancels out in Eq. (2) and therefore does not
need to be calculated. The folding energy change due to a muta-
tion is calculated with the following equation:
ΔΔGð folding mutationÞ ¼ ΔGð folding WTÞ  ΔGð folding mutantÞ
¼ Gð folded WTÞ  Gxðunfolded WTÞ
 Gð folded mutantÞ þ Gxðunfolded mutantÞ:
ð2Þ
Where ΔΔG(folding_mutation) represents the folding energy
change due to a mutation; ΔG(folding_WT) and ΔG(folding_
mutant) are the folding energies of the WT protein and the
mutant, respectively. In addition, many third party structure-
and sequence-based servers were employed to verify our predic-
tion results including Eris, FoldX, I-Mutant 2.0, PolyPhen 2, and
PoPMuSiC (http://troll.med.unc.edu/eris/, http://foldx.crg.es/,
http://folding.uib.es/i-mutant/i-mutant2.0.html, http://genetics.
bwh.harvard.edu/pph2/, http://babylone.ulb.ac.be/popmusic/,
respectively).
Maintenance of zebraﬁsh lines
Zebraﬁsh (Danio rerio) were raised and maintained under stand-
ard conditions as previously described (24). All experiments in-
volving zebraﬁsh were approved by the Institutional Animal
Care and Use Committees of Chungnam National University
(CNU-00393).
Generation of zebraﬁsh mutant lines
The TALEN vectors targeting the second exon of zc4h2 (Supple-
mentary material, Fig. S5) were designed and constructed by
ToolGen (Korea, www.toolgen.com). TALEN vectors were linear-
ized by PvuII and puriﬁed by ethanol precipitation. Subsequently,
mRNAs encoding left and right TALENs were synthesized using
the mMESSAGE mMACHINE T7 Transcription kit (Ambion cata-
logue number AM1344) and puriﬁed by the phenol/chloroform
precipitation. One-cell fertilized embryos were mincroinjected
with TALENmRNAs. Site-speciﬁc TALEN function was examined
by isolation of genomic DNA, target-speciﬁc PCR and T7 endo-
nuclease I assay. Genomic DNAwas extracted from single larvae
or ﬁn-clipped tissues of adults and lysed with genomic DNA iso-
lation buffer (10 m Tris, 50 m EDTA, 200 m NaCl, 0.5% SDS
and 0.5 mg/ml Proteinase K) for 12 h at 55°C. Genomic DNA was
puriﬁed using the phenol/chloroform method. PCR was per-
formed using the following primer pairs and PCR conditions:
zc4h2 exon2 forward primer, 5′-GACCGAGTTTGAAGTCTGG-3′;
zc4h2 exon2 reverse primer, 5′-CACGTTAATATCCGCATGAATG-3′.
Consequently, 130 bp PCR products were puriﬁed by gel extrac-
tion and analyzed by T7 endonuclease I assay (NEB catalogue
number M0302).
Analysis of zebraﬁsh mutants
Plasmid construction
The zebraﬁsh zc4h2 gene was isolated from a 24 hpf zebraﬁsh
cDNA libraryandﬁrst cloned into the pGEM-T EasyVector System
(Promega catalogue number A1360) and then subcloned into the
EcoRI site in the pCS2+ expression vector. Primers used for this
PCR were: zc4h2 forward primer 5′-ATGGCGGCGAGCAAGAGAT
AA-3′, zc4h2 reverse primer 5′-TGTTACTCGTCAGGTTTTCTCTT
G-3′. To construct a Flag-tagged zc4h2 expression vector, PCR
was performed using the same primers and the product was sub-
cloned into the NcoI site in the pCS2 + Flag vector.
Microinjection
For mutant rescue experiments, synthetic capped mRNAs for
zebraﬁsh zc4h2 and human wild-type, L66H, R213W and R18K
ZC4H2 forms were transcribed via the mMESSAGE mMACHINE
SP6 Transcription kit (Ambion catalogue number AM1340)
using the linearized plasmid DNA as a template. To conﬁrm sub-
cellular localization in zebraﬁsh cells, plasmid DNA for the zc4h2-
Flag construct was injected into zebraﬁsh embryos. mRNAs and
plasmid DNA were dissolved in 0.2 M KCl with 0.2% Phenol Red
as a tracking dye, and then microinjected into one to two-cell
stage embryos using a PV820 Pneumatic PicoPump (WPI).
Whole-mount in situ hybridization and immunohistochemistry
Antisense digoxigenin-labeled RNA probes for zc4h2, gad1, glyt2a,
vglut2.1, gata2, gata3, isl1, scn1Lab, vsx2, vsx1, dbx2, nkx6.1 and
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dlx2awere synthesized using a DIG and Fluorescein RNA Labeling
Mix (Roche cataloguenumber 11277073910, 11685619910) according
to themanufacturer’s protocols.Whole-mount in situ hybridization
was carried out as published (25). Whole-mount immunohisto-
chemistry for znp1 was performed as described (24).
Parafﬁn sectioning
For parafﬁn embedding, embryos were dehydrated with ethanol
for 5 min and washed for 10 min in isopropanol. They were then
cleared three times for 10 min in Xylene. Embryos were trans-
ferred to Xylene:parafﬁn (1:1) solution at 60°C for 20 min and
then embedded three times for 20 min with parafﬁn in stainless
steel molds. Embryos were held in position in the pre-warmed
plastic embedding cassette. After trimming, sections (7 µm)
were cut by a microtome and deparafﬁnated with Xylene. The
preparations were mounted with Canada Balsam and examined
using a LEICA DM5000B microscope.
Behavior analysis
For observation of free swimming, 5 dpf wild-type sibling and
zc4h2 mutant larvae were placed on slide glass in embryo media.
Larvae were monitored using a stereomicroscope (LEICA, MZ16),
camera (LEICA DC300FX) and microscope imaging software
(LEICA, IM50). For recording of free swimming, monitor display
was recorded by using Camtasia Studio software (TechSmith, Ve-
sion 7.0.0). For observation of eye, pectoral ﬁn and jawmovement,
5 dpf larvae were transferred onto a glass slide coated with 3%
methylcellulose.
Statistical analysis
To assess the signiﬁcance of differences between wild-type sib-
ling and mutant groups, all data were analyzed using one-way
ANOVA with Dunnett’s post-test. The signiﬁcance level was set
at **P < 0.001, *P < 0.05 versus control group and data were repre-
sented as the means ± SEM (Standard Error of the Means).
Supplementary Material
Supplementary Material is available at HMG online.
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